Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Metilxantinas para las exacerbaciones de la enfermedad pulmonar obstructiva crónica

Información

DOI:
https://doi.org/10.1002/14651858.CD002168Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 22 abril 2003see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Vías respiratorias

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • R Graham Barr

    Correspondencia a: Division of General Medicine, PH‐9 East Room 105, Columbia‐Presbyterian Medical Center, New York, USA

    [email protected]

  • Brian H Rowe

    Department of Emergency Medicine, University of Alberta, Edmonton, Canada

  • Carlos A Camargo

    EMNet Coordinating Center, Massachusetts General Hospital, Boston, USA

Contributions of authors

RG Barr: protocol development, article selection, data extraction, analysis, manuscript preparation.
BH Rowe: protocol development, analysis, manuscript preparation.
CA Camargo Jr: protocol development, article selection, data extraction, analysis, manuscript preparation.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • PE‐1101, HL‐07427, NRSA; Robert Wood Johnson Generalist Physician Faculty Scholar Award (RG Barr), USA.

  • HL‐63841, NIH (CA Camargo Jr), USA.

  • NHS Research and Development, UK.

  • Canadian Institute of Health Research (BH Rowe), Canada.

Declarations of interest

The authors who have been involved in this review have done so without any known conflicts of interest. Dr. Rowe has received research grants from Boehringer‐Ingelheim, GlaxoSmithKline and AstraZeneca; Dr. Camargo has received research grants from these and other pharmaceutical manufacturers. None of the authors were involved with the primary studies.

Acknowledgements

The authors wish to acknowledge the assistance of Stephen Milan, Karen Blackhall, Liz Arnold and Toby Lasserson of the Cochrane Airways Review Group. We are grateful to Gary M. Strauss MD for assistance with article selection and Keith Wrenn MD and Felix Ram for providing unpublished data. Finally, the assistance of Professor Paul Jones (Cochrane Airways Review Group Coordinating Editor) was greatly appreciated.

Version history

Published

Title

Stage

Authors

Version

2003 Apr 22

Methylxanthines for exacerbations of chronic obstructive pulmonary disease

Review

R Graham Barr, Brian H Rowe, Carlos A Camargo

https://doi.org/10.1002/14651858.CD002168

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.